PeerJ
Hernandez-Cascales J.
PMID: 28382232
PeerJ. 2017 Mar 30;5:e3113. doi: 10.7717/peerj.3113. eCollection 2017.
BACKGROUND: Resveratrol is a cardioprotective agent with known antiarrhythmic effects that has recently been shown to inhibit phosphodiesterase (PDE) enzyme activity. Thus, it is possible that resveratrol increases the inotropic effect of sympathomimetic agents, as PDE inhibitors do but,...
Cite
Hernandez-Cascales J. Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium. PeerJ. 2017;5:e3113doi: 10.7717/peerj.3113.
Hernandez-Cascales, J. (2017). Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium. PeerJ, 5e3113. https://doi.org/10.7717/peerj.3113
Hernandez-Cascales, Jesús. "Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium." PeerJ vol. 5 (2017): e3113. doi: https://doi.org/10.7717/peerj.3113
Hernandez-Cascales J. Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium. PeerJ. 2017 Mar 30;5:e3113. doi: 10.7717/peerj.3113. eCollection 2017. PMID: 28382232; PMCID: PMC5376116.
Copy
Download .nbib
